Concepedia

Jingxin Li

JL

Statistics

Publications

136

Citations

8.7K

H-Index

42

Active since

2002

Affiliations

Shandong University(Current)

Qilu Hospital of Shandong University

Northwestern Polytechnical University

University of Liège

Shandong First Medical University

Jingxin Li is an author at Shandong University specializing in life sciences, cell signaling, and signal transduction.

ORCID

Publications per year

2002–2025

136

Publications

136

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan et al. · The Lancet · 2020 · 1.5K citations · Full text

, , +17

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li et al. · The Lancet · 2020 · 1.3K citations · Full text

, , +17

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

Fengcai Zhu, Wenbo Xu, Jielai Xia et al. · New England Journal of Medicine · 2014 · 467 citations · Full text

, , +17

Long-Term Efficacy of a Hepatitis E Vaccine

Jun Zhang, Xuefeng Zhang, Shoujie Huang et al. · New England Journal of Medicine · 2015 · 373 citations · Full text

, , +17

PGC-1α Regulates Expression of Myocardial Mitochondrial Antioxidants and Myocardial Oxidative Stress After Chronic Systolic Overload

Zhongbing Lu, Xin Xu, Xinli Hu et al. · Antioxidants and Redox Signaling · 2010 · 216 citations · Full text

, , +17

1–5 of 136